Australia markets closed

Bio-Gene Technology Limited (BGT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0510-0.0040 (-7.27%)
At close: 03:05PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2024
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
622.507
-
595.078
879.776
573.119
907.58
Gross profit
622.507
-
595.078
879.776
573.119
907.58
Operating expenses
Research development
1,070
1,070
1,979
1,899
1,676
-
Selling general and administrative
1,033
1,033
477.731
513.688
374.571
-
Total operating expenses
3,119
3,119
3,777
3,853
3,038
-
Operating income or loss
-3,119
-3,119
-3,182
-2,974
-2,465
-
Total other income/expenses net
622.941
622.941
0.25
6.478
30.966
-
Income before tax
-2,409
-2,409
-3,096
-2,914
-2,396
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-2,409
-2,409
-3,096
-2,914
-2,396
-
Net income
-2,409
-2,409
-3,096
-2,914
-2,396
-
Net income available to common shareholders
-2,409
-2,409
-3,096
-2,914
-2,396
-
Basic EPS
0.00
-
-0.02
-0.02
-0.02
-0.02
Diluted EPS
0.00
-
-0.02
-0.02
-0.02
-0.02
Basic average shares
104,457
-
167,768
153,338
137,233
119,372
Diluted average shares
104,457
-
167,768
153,338
137,233
119,372